(Hypertension. 2000;35:1085.)
© 2000 American Heart Association, Inc.
Scientific Contributions |
From the Department of Cardiology, Jichi Medical School, Tochigi, Japan.
Correspondence to Uichi Ikeda, MD, PhD, Department of Cardiology, Jichi Medical School, Minamikawachi-Machi, Tochigi 329-0498, Japan. E-mail uikeda{at}jichi.ac.jp
AbstractThe purpose of this
study was to investigate the effects of aspirin-like drugs on nitric
oxide (NO) synthesis in rat vascular smooth muscle cells (VSMCs). We
measured the accumulation of nitrite, a stable oxidation product of
NO, and the expression of inducible NO synthase (iNOS) mRNA and protein
in rat cultured VSMCs. Sodium salicylate, aspirin, and
indomethacin dose-dependently enhanced nitrite
production by interleukin (IL)-1ßstimulated VSMCs at
therapeutic plasma concentration ranges. Increased nitrite
production by aspirin-like drugs was accompanied by increased
iNOS mRNA and protein accumulation in VSMCs. Addition of IL-1ß
activated nuclear factor
B (NF-
B) in VSMCs, but sodium
salicylate did not affect IL-1ßinduced NF-
B activation. The
nonselective lipoxygenase (LO) inhibitor
nordihydroguaiaretic acid inhibited sodium salicylateinduced nitrite
production, whereas the selective 5-LO inhibitor
caffeic acid did not influence production of nitrite. The 12-LO
product 12-HETE dose-dependently enhanced nitrite
production by IL-1ßstimulated VSMCs, whereas the 15-LO
product 15-HETE did not. Our study demonstrates that aspirin and
the aspirin-like drugs, sodium salicylate and
indomethacin, increase NO synthesis in
IL-1ßstimulated VSMCs by upregulation of iNOS transcription via a
12-LO pathway. These effects were independent of NF-
B activation. In
addition to the direct inhibition of platelet function,
aspirin-like drugs may contribute to the reduction of atherothrombotic
risk in myocardial ischemia via enhancing NO production
by VSMCs.
Key Words: nitric oxide aspirin atherosclerosis lipoxygenase cyclooxygenase
This article has been cited by other articles:
![]() |
S. Di Marco, R. Mazroui, P. Dallaire, S. Chittur, S. A. Tenenbaum, D. Radzioch, A. Marette, and I.-E. Gallouzi NF-{kappa}B-Mediated MyoD Decay during Muscle Wasting Requires Nitric Oxide Synthase mRNA Stabilization, HuR Protein, and Nitric Oxide Release Mol. Cell. Biol., August 1, 2005; 25(15): 6533 - 6545. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.L. Mehta, J. Chen, F. Yu, and D.Y. Li Aspirin inhibits ox-LDL-mediated LOX-1 expression and metalloproteinase-1 in human coronary endothelial cells Cardiovasc Res, November 1, 2004; 64(2): 243 - 249. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Ikeda, Y. Maeda, K. Yamamoto, and K. Shimada C-Reactive protein augments inducible nitric oxide synthase expression in cytokine-stimulated cardiac myocytes Cardiovasc Res, October 1, 2002; 56(1): 86 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Evans and P. Piermarini Contractile properties of the elasmobranch rectal gland J. Exp. Biol., January 1, 2001; 204(1): 59 - 67. [Abstract] [PDF] |
||||
![]() |
H. Chen, U. Ikeda, M. Shimpo, M. Ikeda, S. Minota, and K. Shimada Fluvastatin Upregulates Inducible Nitric Oxide Synthase Expression in Cytokine-Stimulated Vascular Smooth Muscle Cells Hypertension, December 1, 2000; 36(6): 923 - 928. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |